Seegnal Inc. subsidiary receives Gold Mark
Analysis based on 7 articles · First reported Apr 14, 2026 · Last updated Apr 14, 2026
The Gold Mark certification for Seegnal through its subsidiary Seegnal eHealth is expected to positively impact its stock price and market reputation, as it signifies enhanced commercialization readiness and trust from healthcare systems. This recognition could lead to increased adoption of Seegnal's clinical decision support solutions, benefiting investors in the healthcare technology sector.
Seegnal, a global leader in clinical decision support solutions, announced that its Israeli operating subsidiary, Seegnal eHealth, has been granted the prestigious Gold Mark by the Israel — Standards Institution of Israel. This high institutional quality distinction is awarded to organizations that have embedded a culture of excellence across their management systems, processes, and product lifecycle. The Gold Mark certification further solidifies Seegnal's commercialization-readiness and its standing as an enterprise-grade platform trusted by leading healthcare systems. Seegnal eHealth received this recognition for holding three quality certification marks: ISO 13485:2016 (Medical Devices Quality Management Systems), ISO 27799 (Information Security Management in Health), and ISO 27001:2022 (Information Security Management Systems). The certificate was signed by Gilad Golub, CEO, and Avital Weinberg, VP of the Quality & Certification Division of the Israel — Standards Institution of Israel.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard